Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CEO INTERVIEW: POWER3 MEDICAL PRODUCTS INC. - HELEN R. PARK (PWRM).


(ANA622) POWER3 MEDICAL PRODUCTS INC. - HELEN R. PARK (PWRM PWRM Pre-Positioned War Reserve Materiel ). Describes the company's business and its background; prospects for the industry, with positive and negative trends; competitive threats; strategic opportunities for the firm including its marketing plans and acquisition potential; management strength and organization; and the financial prospects of the firm looking forward. Sector: Biotechnology. Published date 8/24/09. Tickers featured: PWRM. Complete text approximately 3000 words. Document # ANA622.

CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  INTERVIEWS, The Wall Street Transcript, 67 Wall Street, NY 10005. Voice (212) 952 7433. Fax: (212) 668-9842. E-mail: information@twst.com.
COPYRIGHT 2009 Wall Street Transcript Corporation
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Wall Street Transcript Digest
Date:Aug 23, 2009
Words:91
Previous Article:ANALYST INTERVIEW: INVESTING IN ELECTRONIC DESIGN AUTOMATION u STERLING AUTY u JPMORGAN EQUITY RESEARCH.
Next Article:CEO INTERVIEW: STEEL VAULT CORPORATION u WILLIAM J. CARAGOL (SVUL).
Topics:



Related Articles
Top Public Companies. (2002 Book of Lists).
POWER3 GETS RIGHTS TO NEURODEGENERATIVE DISEASE BLOOD TEST.
Power3 and The Methodist Hospital Research Institute form collaborative research agreement for neurodegenerative disease blood test serum proteins.
Power3 Medical files provisional patent application for biomarker-based method to diagnose Alzheimer's Disease.
NeoGenomics and Power3 to commercialize blood serum-based tests for the early detection of breast cancer and other diseases.
CEO INTERVIEW: STEVEN B. RASH - POWER3 MEDICAL PRODUCTS, INC. (PWRM).
Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles